Hypertension secondary to scavenging of NO remains a limitation in the use of HBOCs (haemoglobin-based
oxygen carriers). Recent studies suggest that
nitrite reduction to NO by deoxyhaemoglobin supports NO signalling. In the present study we tested whether
nitrite would attenuate HBOC-mediated
hypertension using
HBOC-201 (Biopure), a bovine cross-linked, low-
oxygen-affinity haemoglobin. In a similar way to unmodified haemoglobin, deoxygenated
HBOC-201 reduced
nitrite to NO with rates directly proportional to the extent of deoxygenation. The functional importance of HBOC-201-dependent
nitrite reduction was demonstrated using isolated aortic rings and a murine model of
trauma, haemorrhage and
resuscitation. In the former,
HBOC-201 inhibited NO-donor and
nitrite-dependent vasodilation when oxygenated. However, deoxygenated
HBOC-201 failed to affect
nitrite-dependent vasodilation but still inhibited NO-donor dependent vasodilation, consistent with a model in which
nitrite-reduction by deoxyHBOC-201 counters NO scavenging. Finally,
resuscitation using
HBOC-201, after
trauma and haemorrhage, resulted in mild
hypertension ( approximately 5-10 mmHg). Administration of a single bolus
nitrite (30-100 nmol) at the onset of
HBOC-201 resuscitation prevented
hypertension.
Nitrite had no effect on mean arterial pressure during
resuscitation with LR (
lactated Ringer's solution), suggesting a role for
nitrite-HBOC reactions in attenuating HBOC-mediated
hypertension. Taken together these data support the concept that
nitrite can be used as an adjunct
therapy to prevent HBOC-dependent
hypertension.